chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First of all let me start by saying patient was a perfectly healthy child until 7/3/13. He had experienced spit up problems that I had expressed concern about on 7/3/13. I was told he doesn't have acid reflux disease because he hasn't lost weight. On 7/3/13 he had six immunizations, that evening he started running 103-104 temperature and started frequently spitting up. He had been ZANTAC at the 7/3/13 appointment. On 7/8/13 he became sicker and continued to run fever. I called pediatric office and expressed my concern. I was told fever was normal but after I told them I wanted him checked out they said bring him in. He was examined and I was told he doesn't have an ear or throat infection so no need to give an antibiotic. That evening he started throwing up and continued to run a high fever. I called 24 hour nurse hotline because a normally non-crying child became inconsolable. They told me to take to E.R. I did Dr. did urinalysis and chest X-ray. Told me to throw away my thermometer fevers mean nothing. Babysitter called - had a friend who is Dr. On Tuesday July 9th saw doctor did blood work and ultrasound of stomach -viral infection prescribed antibiotic - dehydrated. On July 15th when picked up from babysitter was told she was concerned because he wasn't acting right - head tilted to left all day - first I had noticed on July 18 - still tilted so called Dr - looked at - saw - said no need to go further - I wasn't satisfied - called another pediatric office - saw on July 19th. On 18th I called a friend who has seen before - vaccination injury - as soon as I tell anyone he was fine until shots act like I'm crazy. Have before/after picture asked pediatric office to report - all I got is - it's not from shots - so I'm sure it wasn't reported. Everything is "oh mommy he's fine." Dr examined him - seemed concerned - can't say it is or isn't from shots but definite head tilt - possibly torticollis - sending to Pediatric neurologist to be sure. Follow up 7/26/13. As of 7/22 have already missed over 40 hours of work related to this incident. This is at a job you have to be dead or dying to miss. 7/3 - shots. 7/3 - 7/9 or 7/10 - Ran 103-104 temp, screaming, crying, dehydrated and rash on chest/stomach. 7/8 - Pediatric office. 7/8 - 9-11 pm - ER. 7/9 - Doctor. 7/15 -started or first noticed head tilting to left. 7/18 - Saw Dr. 7/19 - Another pediatric office. As of 7/22 today still tilting head.
Excruciating all over body aches, even eyes, headaches which started in evening after immunization. (myalgia and headaches).
Experienced premature rupture of membranes (broken water) in twin pregnancy at 27 weeks pregnant, admitted to the hospital for monitoring and prevention of both labor and infection. At 28 weeks and 2 days pregnant (July 6, 2021), needed an urgent Caesarean section to deliver both babies, who were subsequently admitted and still remain in the NICU. Birth weights were 2lbs 5oz and 2lbs 8oz.
Muscle and nerve twitches started 2 days later in upper left arm and chest, and shoulder area. By mid week full body twitching. Tingling, pins and needles, burning skin, and numbness to feet. Have seen GP Neurologist and dermatologist.   Symptoms have not abated after 4.5 months.
Rash and itching near the shot; Red; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Rash and itching near the shot) and VACCINATION SITE ERYTHEMA (Red) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE and AMLODIPINE for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced RASH PRURITIC (Rash and itching near the shot) and VACCINATION SITE ERYTHEMA (Red). At the time of the report, RASH PRURITIC (Rash and itching near the shot) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow up received on 07-Jul-2021 contains Non significant information of updated contact details
This spontaneous report was received from a registered nurse referring to an unknown number of patients of unknown age and gender. Nurse reported that unknown number of doses of improperly stored RECOMBIVAX HB (lot # not reported), had been administered to the patients. No adverse effects reported. This is one of several reports from the same reporter source. Additional information has been requested.
Chronic Uticaria- hives. All over body not at injection site. Began 2 weeks after booster. Appears on legs, arms. Frets, hands, chest. Everywhere
Local induration, redness, temp of 102 x 2. 5/30 fever, 5/31 redness, induration.
no adverse event; Patient was administered expired GARDASIL 9; This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 14-SEP-2022, the patient was vaccinated with an expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # 1687290 exp date reported as 09-SEP-2022 but upon internal validation established as 06-SEP-2022).
Patient received vaccine around 11 am by evening the arm was red and swollen and warm, and aching around 10 pm the patient started becoming dizzy and vomited 3 times. patient went to sleep and her fingers and toes curled up and became rigid overnight. everything was resolved by morning time when she reported to me. except the arm was still swollen and achy, but much better since the evening before. advised pt to report to doctor if anything else occurs, or if arm swelling increase or becomes painful
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of 17 years old adolescent and unknown gender. On 26-SEP-2014 the patient was vaccinated with an improperly stored GARDASIL (lot J015378, expiration date 09-APR-2016) (dose, route, were not reported). No adverse effect was reported. The outcome of events reported is unknown. No product quality complaint was involved. This is one of several reports received from the same source. Additional information has been requested.
dizzy, lightheaded, nausea, headache, sore arm, swollen lymph between arm and shoulder by the injection site, bruising at the injection site.
60 yo male advised he received a PNEUMOVAX vaccine per recommendations of Dr. sometime in 2009. He advised vaccine was given following one of his routine asthma evaluations with her. He advised MD on 9/21/2009 exam that he had experienced "systemic reactions to PNEUMOVAX". He describes this systemic reaction as his right deltoid and upper arm (2/3 of lateral surface of arm) being hot to touch, very swollen, tender to touch, site being red blotchy and itched. It took 3-4 days for this reaction to resolve and was treating with NSAIDs. He advised his wife looked at the VIS form he was provided and said "you have all the side effects listed", but as it was a Saturday, the clinic was closed and he did not advise anyone till later. He denied any SOB other than his typical asthma, no fever, headaches, myalgia, arthralgia (other than site pain), rash/hives elsewhere on body, or any other systemic reaction. He advised he continued to receive other vaccines while working to include Hepatitis B series, Tetanus diphtheria (unsure if Tdap) about 2013, and yearly influenza vaccines at local pharmacy without reactions (2009-2014).
I got my Booster shot on December 16. I had nausea and headache for a day after. Then again around Christmas I started to feel extremely fatigue. I was schedule to have a fine needle biopsy of a thyroid nodule on December 28th (schedule in December before shot) and when I went to the endocrinologist i let her know my thyroid was hurting on the opposite side of the nodule. The endocrinologist did an ultra sound and said I didn?t have a nodule but had Thyroiditis. She sent me for extra bloodwork. I didn?t get an FNA biopsy. I got more sick after this visit. I had extreme fatigue, headache, nausea, elevated resting heart rate (iwatch alerted me to a resting heart rate of 150). I could barely get through 1/4 of my daily activity (laundry, cooks dinner). I had three nights of laying on the couch with low grade fever one day. I did a teledoc apt instead of emergency room to get instructions. I then made an apt that Monday on Tuesday January 4th with my primary care as she was the first doctor I could get into. My primary care prescribed a beta blocker. I saw the endocrinologist the next day. Even if I had thyroid issue it was not as pronounced until after the shot. Also the shot made me very sick for a day and 1/2 which I think may have been worse if Thyroiditis was coming on. At the time I was not diagnosed with Thyroiditis.
Information has been received from a registered nurse, for GARDASIL, a Pregnancy Registry product, concerning a 29 year old female who on 03-SEP-2010 was vaccinated with the first dose of GARDASIL (therapy route and lot # not provided). On 09-MAY-2011 the patient was vaccinated with the second dose of GARDASIL (therapy route and lot # not provided). On 29-MAY-2011 patient had a positive urine pregnancy test. Patient's last menstrual period (LMP) and estimated delivery date (EDD) were not provided. The patient was tested on 05/09/2011 also and at that time the test results were negative. There were no adverse events reported. It was unspecified if patient sought medical attention. Additional information is not expected.
Here is the patient info for the temp excursion; Here is the patient info for the temp excursion/beyond use date excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Here is the patient info for the temp excursion/beyond use date excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Here is the patient info for the temp excursion) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Here is the patient info for the temp excursion/beyond use date excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Here is the patient info for the temp excursion). On 20-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Here is the patient info for the temp excursion/beyond use date excursion) had resolved. At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Here is the patient info for the temp excursion) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment and concomitant medications were provided.
Expected fever where shot was given as well as muscle tenderness.. Joint pain, exhaustion but no fever. Was NOT expecting  swelling  with heated hives BELOW shot sight near elbow. As if serum traveled through muscle / tendon. Second day joint pain from wrist to shoulder with continued swelling, fever & hive. Fevered, swollen hive above elbow has continued to current date September 3 and reason for form being filed. Joint pain has subsided. Expect fevered hive will do the same in time. REGARDING ITEM 17 ABOVE: NO OTHER VACCINE WAS ADMINISTERED DURING THIS VISIT
Severe headache with blurry vision and photophobia. Had MD visit on 3/10/03 and will see MD 3/12/03. 3/12/03 con't to have increase headache without relief. State: VAERS: HD notified. Will see neurlogist 3/13/03. Client saw PMD. Still symptomatic.
Patient presents to the primary care clinic on July 3, 2013 with complaint of rash beginning 2 days after tetanus shot. No pain, no itch, no trouble swallowing and no fever. Rash presented as red flat areas above upper lip, both upper extremities and back and chest area x last few days. Denies having any new medications or food along with no new detergents. Was given prednisone. Rash resolved within a few days.
2/11 -13/21   Sore arm first 2 days.  Then I felt fine with no effects until the following week.  On 2/18 my arm begin to itch at site of injection.  2/21 itching subsided but I noticed a red circular area around injection site.  The area also feels warm.  I feel okay physically.  Today 2/24, the red circular area is still present.
28-year-old female presents for evaluation of a syncopal episode and head trauma several hours after receiving her second dose of Covid vaccine yesterday.        She works in the ER night shift at a hospital.        Yesterday (10/21/2021), her shift ended at 0700. She then got the 2nd dose of the Moderna Vaccine at 0900.        Later that evening at 2000, patient states that she stood up from a chair to walk over to the kitchen when she experienced prodromal symptoms [quotation things got quiet in my head"]. Prior to this, the last thing that she ate was when her shift ended at 0900. Patient has had 3-4 syncopal episodes previously, the last time was 8 years ago, and therefore knew that she should sit down and wait episode. Once she felt better, she stood up to walk again and at that point had complete LOC.        Patient states that this episode was witnessed by her son's father and her neighbor, who let her know that during this time she did not demonstrate any tonic-clonic seizure activity, but hit the occiput of her head hard on the hardwood floor when she fell. Apparently, this episode lasted for a few minutes before self resolving. Patient denies any post ictal state symptoms besides the feeling of head heaviness.        Following this, patient finished her dinner, then went to bed one hour after the episode.        Of note:        -Patient's prior PCP had referred her to neurology for evaluation and rule out of absence seizures. Patient no showed that appointment. However, she did have an EEG done around that time at the hospital which was normal.        -Patient had a DVT in her right lower extremity in 2016 when she was pregnant with her son. Repeat ultrasound in 2019 showed it was resolved.        -Patient notes that she has a family history of multiple family members (~5) on her maternal side passing away from aneurysms in their 30s.
Malaise, mild fever, generalized weakness, reverted to using a walker from not using it the weeks prior.
Asthma attack; This is a spontaneous case, initially reported by other health professional via Med Communications (reference number: SEQ19-05194) on 26-Jul-2019, concerning a 52-year-old, female patient.  The patient's relevant medical history included a history of asthma.  The patient did not have concomitant medications.    On 18-Oct-2019, the patient was administered Flucelvax QIV [Influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 259814 and expiry date: 30-Jun-2020] for influenza prophylaxis.  On the same day of vaccination, later that evening, the patient experienced an asthma attack and same thing happened the next morning as well. The patient reported  she was feeling  like her throat was 'closing up' and had to use her inhaler and take Benadryl.  On 19-Oct-2019 the outcome of the event was considered resolved.  The reporter assessed the case as non-serious.  Company comment: The patient experienced asthma (reported as asthmatic attack) on the same day of vaccination with the suspect product, Flucelvax QIV. Chronology is plausible. The patient was previously diagnosed with asthma and the disease itself is characterised with numerous attacks that can be provoked with multiple factors. Considering all the above mentioned, causal role of the suspect product cannot be totally excluded and is assessed as unlikely related.; Sender's Comments: The patient experienced asthma (reported as asthmatic attack) on the same day of vaccination with the suspect product, Flucelvax QIV. Chronology is plausible. The patient was previously diagnosed with asthma and the disease itself is characterised with numerous attacks that can be provoked with multiple factors. Considering all the above mentioned, causal role of the suspect product cannot be totally excluded and is assessed as unlikely related.
62 year old patient was given the Adjuvanted Fluad Quadrivalent for 65+ in error
Second dose / before the 2 months recommended in / schedule; This case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too short in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The patient received the second dose of shingrix before the 2 months recommended in the shingrix schedule, which led to shortening of vaccine schedule. The reporter consented to follow up.
COVID arm; injection site hot to the touch; injection site really hard; big round red rash on her injection arm; injection arm itches crazy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm), VACCINATION SITE WARMTH (injection site hot to the touch), VACCINATION SITE INDURATION (injection site really hard), VACCINATION SITE RASH (big round red rash on her injection arm) and VACCINATION SITE PRURITUS (injection arm itches crazy) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Sep-2021, the patient experienced VACCINATION SITE REACTION (COVID arm), VACCINATION SITE WARMTH (injection site hot to the touch), VACCINATION SITE INDURATION (injection site really hard), VACCINATION SITE RASH (big round red rash on her injection arm) and VACCINATION SITE PRURITUS (injection arm itches crazy). At the time of the report, VACCINATION SITE REACTION (COVID arm) had not resolved and VACCINATION SITE WARMTH (injection site hot to the touch), VACCINATION SITE INDURATION (injection site really hard), VACCINATION SITE RASH (big round red rash on her injection arm) and VACCINATION SITE PRURITUS (injection arm itches crazy) outcome was unknown.            No concomitant medications were provided.  The patient received both doses of the Moderna COVID-19 vaccine. The patient developed what is called COVID arm. It happened after the second dose and still has it. It was a big round red rash on injection arm that itches crazy, was hot to the touch and really hard. The red mark appeared almost immediately after the second dose.  No treatment medications were provided.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 11-DEC-2009, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster with complications. On or about 05-JUL-2016, the patient was treated at a clinic for a persistent vesicular outbreak accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Low grade fever for 24 hrs, headache for 24 hr, left arm where the shot was given was sore for 48 hrs
Pericarditis Asthma Pt developed pericarditis and asthma 8 months after vaccine, requiring medication and hospitalizations.
Itchy LUA, redness measuring 8 cm x 9 cm. BP 144/82 (pulse 85), 97% O2 sat. Given Benadryl 50 mg PO.
Shoulder pain and weakness started a few weeks after administering soon followed by feet numbness and fatigue. Guillain Barre diagnosed 12/27/2014.
Pfizer COVID vaccine #3 given 8/26/22, lot # FD8448; pt had a positive at home COVID test on 4/20/22; was given monoclonal antibodies the following day; 4/23/22 admitted to hospital with worsening hypoxia x past 4 days; pt placed on BiPAP; dexamethasone, ABX, DuoNeb, remdesivir; pt was transitioned to DNR/comfort care and passed away in the hospital
Pt received varicella vaccine 10/04/2001. Was diagnosed with chicken pox in office today 8/30/04.
shot #1  developed large red, painful lump at injection site the night that I got the shot. The next day It was difficult to move my arm from the pain. Each day it got better. Two weeks later I developed a large painful lump and red circle again at the injection site, it started to get better after about 3 days. 6 weeks after the first shot, my injection site was still tender to touch.   shot #2. I developed an even larger swollen, red, painful and sometimes itchy lump at the injection site within approximately 8 hours after the shot. Today is day 9, it's better but I still have some mild swelling and moderate tenderness with touch.
Patient noted feeling lightheaded for 5 seconds within 10 minutes of vaccine dose. Monitored for 20 minutes afterward with no change in vital signs or patient condition.
Soreness around the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced soreness around the injection site. The caller did not want to answer any adverse event questions.  The patient briefly mentioned that she had heard a lot of people who had experienced many reactions for 2 days after getting Shingrix vaccine. No further details were provided.